EssilorLuxottica (OTCMKTS:ESLOY) Sees Strong Trading Volume – Here’s What Happened

Posted by Linda Flegge on Sep 3rd, 2026

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY – Get Free Report) shares saw an uptick in trading volume on Tuesday . 64,803 shares traded hands during trading, a decline of 48% from the previous session’s volume of 123,702 shares.The stock last traded at $92.77 and had previously closed at $92.8350.

Wall Street Analysts Forecast Growth

ESLOY has been the topic of several recent research reports. The Goldman Sachs Group lowered shares of EssilorLuxottica from a “buy” rating to a “hold” rating in a research report on Tuesday, July 14th. Zacks Research upgraded shares of EssilorLuxottica from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 18th. Finally, Deutsche Bank Aktiengesellschaft initiated coverage on shares of EssilorLuxottica in a research report on Tuesday, May 12th. They set a “hold” rating for the company. Two investment analysts have rated the stock with a Strong Buy rating, four have given a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy”.

Check Out Our Latest Stock Analysis on EssilorLuxottica

EssilorLuxottica Stock Down 0.3%

The company has a current ratio of 0.99, a quick ratio of 0.70 and a debt-to-equity ratio of 0.17. The firm has a 50-day simple moving average of $95.59 and a two-hundred day simple moving average of $107.07.

EssilorLuxottica Company Profile

(Get Free Report)

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.